BUY : AUROPHARMA25NOV25FUT( AUROPHARMA ) [46473]

Aurobindo Pharma’s technical chart currently reflects a neutral-to-mildly bearish undertone. The stock is trading just below major moving averages (including 20, 50, 100, and 200-DMA), and most short-term averages (5, 10, 20-day) are in ‘sell’ mode. Momentum oscillators like RSI (around 49) and MACD give neutral-to-weak signals, while Stochastic RSI is in the oversold region, hinting at possible consolidation before any strong bounce. The price action is witnessing support around ₹1,085–1,100, while resistance is seen near ₹1,120–1,130. Unless the stock decisively closes above these resistance levels with volume, further upward movement may be capped. For now, Aurobindo Pharma may remain range-bound with a possibility of a short-term pullback only if support holds and overall market sentiment improves.